Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Santhera Pharmaceuticals Holding AG
SANNCurrent price
8.48 CHF
-0.02 CHF (-0.24%)
Last closed
8.45 CHF
Company
www.santhera.com
ISIN
CH0027148649
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
105 855 937 CHF
Yield for 12 month
-14.77 %
1Y
3Y
5Y
10Y
15Y
SANN
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland. Address: Hohenrainstrasse 24, Pratteln, Switzerland, 4133
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.26 CHFP/E ratio
1.5043Dividend Yield
–Current Year
+104 499 594 CHF
Last Year
+7 554 224 CHF
Current Quarter
+7 133 702 CHF
Last Quarter
+7 133 702 CHF
Current Year
+100 587 530 CHF
Last Year
+3 923 183 CHF
Current Quarter
+4 497 861 CHF
Last Quarter
+4 497 861 CHF
Key Figures SANN
1 year
3 years
5 years
10 years
EBITDA
57 896 511 CHF
Operating Margin TTM
PE Ratio
1.5043
Return On Assets TTM
39.2 %
PEG Ratio
–
Return On Equity TTM
23.74 %
Wall Street Target Price
22.26 CHF
Revenue TTM
114 823 599 CHF
Book Value
4.15 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
258.3 %
Dividend Yield
–
Gross Profit TTM
-5 420 280 CHF
Earnings per share
5.81 CHF
Diluted Eps TTM
5.81 CHF
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
55.34 %
Dividend Analytics SANN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SANN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.07.2023
Dividend Date
08.09.2022
Stock Valuation SANN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
1.5043
Forward PE
–
Enterprise Value Revenue
1.0089
Price Sales TTM
0.9219
Enterprise Value EBITDA
1.3567
Price Book MRQ
2.179
Financials SANN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SANN
For 52 weeks
8.19 CHF
11.56 CHF
50 Day MA
9.19 CHF
Shares Short Prior Month
–
200 Day MA
9.42 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart